Climb Bio, Inc. CLYM

Set alert

Price alert · CLYM

All alert types
9.74 USD -0.51 -4.98%

At close · Nov 2

9.74 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
9.74 × 2
Ask
9.75 × 2
9.69 Day range 10.44
1.64 52-week range 17.84
YTD
+143.50%
1 year
+375.12%
Open
10.25
Prev close
10.25
Mkt cap
559.43M
Vol
1.15M
Avg vol
1.41M
EPS
-0.82
P/E
0.00
Div yield
0.00%
More statistics
Low
9.69
High
10.44
Forward P/E
-16.92
Beta
0.08
Short ratio
5.77
Inst. own
105.23%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
13.42
200-d avg
8.11
1y target
22.86

5D chart

Chart tools
Interval

Signals (97)
NameTimeAgo
SMA: BearishNov 2, 10:30 AM16 hours ago
MACD: Sell SignalNov 2, 10:30 AM16 hours ago
SMA: BullishNov 2, 10:20 AM16 hours ago
SMA: BearishNov 2, 10:15 AM16 hours ago
SMA: BullishOct 30, 3:25 PM3 days ago
MACD: Buy SignalOct 30, 3:25 PM3 days ago
MACD: Sell SignalOct 30, 3:15 PM3 days ago
SMA: BearishOct 30, 3:00 PM3 days ago
SMA: BearishOct 30, 3:00 PM3 days ago
SMA: BullishOct 30, 2:55 PM3 days ago
SMA: BearishOct 30, 2:50 PM3 days ago
SMA: BullishOct 30, 2:20 PM3 days ago
MACD: Buy SignalOct 30, 2:20 PM3 days ago
MACD: Sell SignalOct 30, 2:10 PM3 days ago
SMA: BearishOct 30, 2:00 PM3 days ago
MACD: Buy SignalOct 30, 1:50 PM3 days ago
SMA: BearishOct 30, 1:00 PM3 days ago
SMA: BullishOct 30, 12:55 PM3 days ago
SMA: BearishOct 30, 11:45 AM3 days ago
SMA: BullishOct 30, 11:40 AM3 days ago

Newest 20 of 97.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 22.86 +134.7% upside
Target (low)
18.00
Target (mean)
22.86
Target (high)
35.00
Ratings (0m) 14 14 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy12
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 14
  • 1 month ago 14
  • 2 months ago 15
  • 3 months ago 14

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

CLYM analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.195-0.23 – -0.16-0.19-2.6%00.0%8
Next quarter-0.2075-0.25 – -0.16-0.26+20.2%00.0%8
Current year-0.77875-0.85 – -0.70-0.88+11.5%00.0%8
Next year-1.05-1.44 – -0.76-0.77875-35.4%535.71K0.0%9

Upgrades and downgrades

The latest rating changes

CLYM analyst upgrades and downgrades
DateFirmActionFromTo
Aug 24, 2026HC Wainwright & Co.MaintainedBuyBuy
Aug 19, 2026WedbushReiteratedOutperformOutperform
Aug 7, 2026Truist SecuritiesMaintainedBuyBuy
Jul 27, 2026WedbushMaintainedOutperformOutperform
Jun 24, 2026HC Wainwright & Co.ReiteratedBuyBuy
Jun 12, 2026WedbushReiteratedOutperformOutperform
Jun 11, 2026BTIGMaintainedBuyBuy
Jun 8, 2026GuggenheimInitiated—Buy
Jun 8, 2026BTIGReiteratedBuyBuy
May 12, 2026HC Wainwright & Co.MaintainedBuyBuy
May 8, 2026WedbushMaintainedOutperformOutperform
May 6, 2026BTIGMaintainedBuyBuy
May 5, 2026Chardan CapitalInitiated—Buy
Apr 21, 2026OppenheimerMaintainedOutperformOutperform
Apr 15, 2026MizuhoInitiated—Outperform
Apr 8, 2026BTIGReiteratedBuyBuy
Mar 24, 2026B. Riley SecuritiesInitiated—Buy
Mar 18, 2026Truist SecuritiesInitiated—Buy
Mar 11, 2026Raymond JamesInitiated—Strong Buy
Mar 10, 2026HC Wainwright & Co.MaintainedBuyBuy
Mar 6, 2026WedbushMaintainedOutperformOutperform
Mar 6, 2026BairdMaintainedOutperformOutperform
Mar 5, 2026WedbushInitiated—Outperform
Feb 13, 2026Piper SandlerInitiated—Overweight
Dec 30, 2025Freedom BrokerInitiated—Buy
Dec 18, 2025HC Wainwright & Co.MaintainedBuyBuy
Oct 16, 2025William BlairInitiated—Outperform
Oct 16, 2025BTIGReiteratedBuyBuy
Oct 13, 2025HC Wainwright & Co.Initiated—Buy
Sep 30, 2025BTIGMaintainedBuyBuy